Demetrios Braddock, M.D., Ph.D.
Scientific Founder, Chairperson of Scientific Advisory Board and Board Observer
Demetrios Braddock is an Associate Professor at Yale University, where he practices hematopathology, and leads a laboratory investigating questions at the intersection of disease pathogenesis and biophysical chemistry. Dr. Braddock has made important contributions to the understanding of the histopathology of disorders of aberrant calcification. As the scientific founder of Inozyme Pharma and the Chairperson of the Scientific Advisory Board, Dr. Braddock continues to collaborate with the company. Dr. Braddock earned his M.D. from the University of Chicago Pritzker School of Medicine and received his Ph.D. in Biochemistry from the University of Chicago. He also trained at the National Institutes of Health in Pathology and Chemical Physics.